dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Montero-Conde, Cristina |
dc.contributor.author | Leandro-García, Luis Javier |
dc.contributor.author | Martínez-Montes, Ángel M. |
dc.contributor.author | Martínez, Paula |
dc.contributor.author | Moya, Francisco J. |
dc.contributor.author | Letón, Rocío |
dc.contributor.author | Zafon Llopis, Carles |
dc.date.accessioned | 2022-11-03T06:46:36Z |
dc.date.available | 2022-11-03T06:46:36Z |
dc.date.issued | 2022-08 |
dc.identifier.citation | Montero-Conde C, Leandro-García LJ, Martínez-Montes ÁM, Martínez P, Moya FJ, Letón R, et al. Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers. Clin Transl Med. 2022 Aug;12(8):e1001. |
dc.identifier.issn | 2001-1326 |
dc.identifier.uri | https://hdl.handle.net/11351/8378 |
dc.description | Mutació del promotor TERT; Expressió gènica subtelomèrica; Escurçament dels telòmers |
dc.description.sponsorship | This work was supported by Projects PI17/01796 and PI20/01169 [Instituto de Salud Carlos III (ISCIII), Acción Estratégica en Salud, cofinanciado a través del Fondo Europeo de Desarrollo Regional (FEDER)] and Comunidad de Madrid (S2017/BMD-3724; TIRONET2-CM) to MR. CM-C was partially supported by a grant from the Fundación Científica Asociación Española Contra el Cáncer (AIO15152858 MONT). LJL-G was supported both by the Banco Santander Foundation – CNIO Fellowship and by ‘la Caixa’ Foundation (ID 100010434), under agreement LCF/BQ/PI20/11760011. AMM-M was supported by CAM (S2017/BMD-3724; TIRONET2-CM). MM was supported by the Ministerio de Ciencia, Innovación y Universidades (Spain; ‘Formación del Profesorado Universitario – FPU’ fellowship (FPU18/00064)). We thank CNIO Biobank for their support with the frozen specimens processing. We thank the Spanish National Tumor Bank Network (RD09/0076/00047) for the support in obtaining tumour samples, and all patients, physicians and tumour biobanks involved in the study. |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Clinical and Translational Medicine;12(8) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Tiroide - Càncer - Prognosi |
dc.subject | Tiroide - Càncer - Aspectes genètics |
dc.subject | Telòmer |
dc.subject.mesh | Thyroid Neoplasms |
dc.subject.mesh | /genetics |
dc.subject.mesh | Telomere |
dc.subject.mesh | Prognosis |
dc.title | Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/ctm2.1001 |
dc.subject.decs | neoplasias de la tiroides |
dc.subject.decs | /genética |
dc.subject.decs | telómero |
dc.subject.decs | pronóstico |
dc.relation.publishversion | https://doi.org/10.1002/ctm2.1001 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Montero-Conde C] Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain. [Leandro-García LJ, Martínez-Montes ÁM, Letón R] Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Martínez P] Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Moya FJ] Molecular Cytogenetics Unit, Human Cancer Genetics Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain. [Zafon C] Servei d’Endocrinologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35979662 |
dc.identifier.wos | 000842532600001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |